ITULAZAX
"ITULAZAX" is a word mark owned by ALK-Abelló A/S, filed at the EUIPO on October 31, 2017. It is registered and covers classes 5, 42 and 44.
- Status
- Registered
- Since March 9, 2018
- Filed
- October 31, 2017
- Registered
- February 25, 2018
- Expires
- October 31, 2027
- Application no.
- 017415365
- Registration no.
- 017415365
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 3 classes
Who owns ITULAZAX
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
ALK-Abelló A/S
Representative
Patrade A/S
Patrade A/S
What the mark covers
The products and services ITULAZAX is filed for, grouped by Nice class.
Pharmaceutical and veterinary preparations, including pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; diagnostic preparations for medical purposes, diagnostic reagents and diagnostic testing materials for medical use; pharmaceutical preparations in the form of injectable pharmaceuticals
Scientific, technological, medical and pharmacological research services and design relating thereto; scientific and medical laboratory services, clinical trials
Medical services and medical healthcare services; medical consulting services, including counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; providing patient support relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, also electronically or digitally, eg through a website; providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, also electronically or digitally, eg through a website; medical diagnostic services
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2024/111 Section C.2.2
- Bulletin 2019/231 Section C.2.2
- Bulletin 2018/085 Section B.4.2
- Bulletin 2018/041 Section B.1
- Bulletin 2017/219 Section A.1
About ITULAZAX
Who owns the trademark "ITULAZAX"?
The EUIPO trademark "ITULAZAX" (application 017415365) is owned by ALK-Abelló A/S.
What is the status of "ITULAZAX"?
Its status at the EUIPO is: registered.
When was "ITULAZAX" registered?
It was registered on February 25, 2018 and is due to expire on October 31, 2027.
Get this data via the API
Everything on this page comes from the Signa API. Pull ITULAZAX and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d4594-bb6f-75e6-8b42-9796fe413eb9
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d4594-bb6f-75e6-8b42-9796fe413eb9",
"object": "trademark",
"mark_text": "ITULAZAX",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "017415365",
"filing_date": "2017-10-31",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "ALK-Abelló A/S",
"entity_id": "ent_019eb6f7-d7a6-7420-874f-900c24eb0227"
}
]
}